Furthermore, in this patient cohort, elevated serum HMGB1 was associated with antigen-specific T cell responses and the degree of HMGB1 expression in the tumor microenvironment (TME) was correlated with improved patient survival [57]. This evidence concerns the gene HMGB1 and neoplasm.